文献速递白血病

意大利CML患者COVID-19感染一年报告

COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
PubMed 文献 · Br J Haematol · 2021-10-11

Limited information is available on the impact of the COVID-19 pandemic on the management of chronic myeloid leukaemia (CML).…

临床怎么用

  • CML患者感染SARS-CoV-2后需关注TKI停用情况及住院和呼吸支持需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Limited information is available on the impact of the COVID-19 pandemic on the management of chronic myeloid leukaemia (CML). The Campus CML network collected retrospective information on 8 665 CML patients followed at 46 centres throughout Italy during the pandemic between February 2020 and January 2021. Within this cohort, we recorded 217 SARS-CoV-2-positive patients (2·5%). Most patients (57%) were diagnosed as having SARS-CoV-2 infection during the second peak of the pandemic (September 2020 to January 2021). The majority (35%) was aged between 50 and 65 years with a male prevalence (73%). Fifty-six percent of patients presented concomitant comorbidities. The median time from CML diagnosis to SARS-CoV-2 infection was six years (three months to 18 years). Twenty-one patients (9·6%) required hospitalization without the need of respiratory assistance, 18 (8·2%) were hospitalized for respiratory assistance, 8 (3·6%) were admitted to an intensive care unit, while 170 (78%) were only quarantined. Twenty-three percent of patients discontinued tyrosine kinase inhibitor (TKI) therapy during the infection. Twelve patients died due to COVID-19 with a mortality rate of 5·5% in the positive cohort and of 0·13% in the whole cohort. We could also document sequelae caused by the SARS-CoV-2 infection and an impact of the pandemic on the overall management of CML patients.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Breccia M, Abruzzese E, Accurso V, et al. COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. Br J Haematol. 2021. PMID: 34636033. doi:10.1111/bjh.17890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。